Abstract
Five series of tetrahydrobenzothieno [2,3- [4,3-c] pyrimidin-3-ylsulfanyl)acetamides 10a-c. Preliminary antimicrobial testing revealed that compounds 4a and 10b were the most active among the tested compounds against C. albicans showing IZ = 22 mm and MIC = MBC = 31.25 μg/ml, with no significant antibacterial activity. Compounds 6b and 6c showed the highest antibacterial activity against S. aureus (IZ = 21 mm, MIC = 62.5 μg/ml, MBC = 125 μg/ml for 6b; IZ = 21 mm, MIC = MBC = 125 μg/ml for 6c). Compounds 4c and 6c showed the highest antibacterial potency against P. aeruginosa among the tested compounds (IZ = 19-20 mm, MIC = MBC = 62.5 μg/ml). None of the tested compounds showed significant antibacterial activity against E. coli.
Introduction
Thienopyrimidines are potential bioactive molecules as they are structural analogs of biogenic purines and can be considered as potential nucleic acid antimetabolites. They are characterized by a broad spectrum of biological activities. Thienopyrimidine derivative Ia showed significant antibacterial and antimycobacterial activity [1, 2] (Fig.1 ) while compound Ib was proved to possess anti-inflammatory activity [3] . Moreover, compound II displayed IC 50 of 0.019 and 0.83 µg/ml against cyclin dependant kinases Cdk4 and Cdk2, respectively. Thus it might be useful for treatment of hyperproliferative diseases such as cancer [4] .
From the standpoint of biological activity, fused heteroaromatic systems are often of much greater interest than the constituent monocyclic compounds. The appearance of qualitatively new properties of an annelated molecule, enlargement of the possibility of varying pharmacophore groups in different positions of the molecule and the ability of the latter to interact with a wider spectrum of receptors adopting various conformations are apparently of crucial importance [5] . Several 2,3-disubstituted tetrahydrobenzo [b] thienopyrimidinone derivatives exhibited both antibacterial and antifungal activities [6] . Compound IIIa (Fig. 1) , as an example, showed comparable potency to Nystatin [6] . On the other hand, compound IIIb exhibited more potent analgesic and anti-inflammatory activities with lower ulcerogenic index than the reference standard Diclofenac sodium [7] . In addition, introduction of a pyrazolyl or pyrazolinyl moiety at 4-position of tetrahydrobenzothienopyrimidine nucleus gave compounds IVa,b that showed broad spectrum of antimicrobial activity [8, 9] . Furthermore, inclusion of thienopyrimidine nucleus within a tetracyclic system afforded large number of bioactive derivatives (Fig.1 ). Among such compounds, dihydronaphthothienopyrimidine derivatives IVc showed antimicrobial activities against B. subtilis, E. coli., Aspergillus niger and C. albicans [10] . Their ester-containing derivatives demonstrated more antimicrobial activities than the corresponding cyano-containing analogs. Tetrahydrobenzothieno[3,2-e]imidazo[1,2-c]pyrimidine V was found to exhibit antibacterial activity comparable to that of Ampicillin against B. cereus and S. typhi and higher activity than Nystatin against A. alternata and C. corchori [8] . While octahydrobenzothieno [2,3-d] imidazo[1,2-a]pyrimidine VI exhibited a potent blood platelet aggregation inhibition activity in vivo [11] . The tetrahydrobenzothieno[3,2-e]-triazolo [4,3-c] pyrimidine VII was almost as potent as Nystatin against C. albicans exhibiting MBC of 15.62 µg/mL [12] . On the other hand, tetrahydrobenzothieno [3,2- Some selected models of thienopyrimidine derivatives possessing various pharmacological activities.
In view of the above and in continuation of our research program concerned with structural modification of certain biologically active heterocyclic nuclei with the purpose of enhancing their biological activity [14] [15] [16] [17] [18] [19] . We reported herein the synthesis of several novel analogs of the tetrahydrobenzothienopyrimidine system containing 4-substituted amino (4a-d) or 4-substituted methylidenehydrazino (6a-c) functions (Fig. 2) in an attempt to improve the antimicrobial profile of compounds containing the tetrahydrobenzothienopyrimidine ring system. Furthermore, the wide range of bioactivities displayed by pyrazoles which include antimicrobial [20] [21] [22] , antiviral [23, 24] and anticancer [25] [26] [27] activities encouraged us to synthesize hybrid analogs that incorporate a 3,5-disubstituted pyrazolyl ring with tetrahydrobenzothienopyrimidine in one framework (7a,b). In addition, we prepared two series of the tetracyclic [1] 
Results and Discussion

Chemistry
The synthetic routes of the proposed compounds are outlined in Schemes 1 and 2. [29, 30] which was treated with phosphorous oxychloride to afford the corresponding chloro derivative 3 [31] . Reacting 3 with the appropriate amine in DMF at 80°C or heating under reflux with hydrazine hydrate [32] led to the target compounds 4a-d and 5, respectively. The IR spectra of 4a-d showed the presence of C-N bands at 1112-1138 cm -1 which was not present in the precursor. The 1 H NMR spectra of 4a-d showed signals for the protons of the substituted amino function at the 4-position in addition to the signals for C 2, 5-8 -H of the tetrahydrobenzothienopyrimidine nucleus at their expected chemical shifts. 13 4 , respectively. In addition, it showed a signal for the methine carbon at the 2-position at 151.09 ppm. The peaks due to quaternary carbon atoms of the structure disappeared on DEPT experimentation. The structure of 4a was confirmed by its 13 C NMR coupled spectrum which showed the quaternary carbon C 4a as a singlet at 121.38 ppm, while the quaternary carbon C 4b appeared as a triplet at 127.06 ppm indicating the presence of a neighboring CH 2 . In addition, each of the signals at 162.03 and 167.75 ppm corresponding to quaternary carbons C 9a and C 4 , respectively appeared as doublet due to meta coupling with C 2 -H. 13 C NMR spectrum of 4c showed the signals corresponding to the tetrahydrobenzothienopyrimidine carbons present almost at the same chemical shift as in compound 4a. In addition, the spectrum showed three highly shielded signals due to the equivalent piperazine C 2 & C 6 and piperazine C 3 & C 5 at 50.12 and 52.60 ppm, respectively and the benzyl-CH 2 at 62.98 ppm. It also showed three signals due to the five methine carbons in the aromatic region indicating the equivalency between the two ortho and the two meta carbons of the phenyl moiety and a deshielded signal for the phenyl C 1 quaternary carbon. 
Sch. 2.
The peaks due to quaternary carbon atoms of the structure disappeared on DEPT experimentation. The IR spectrum of 5 showed three NH absorption bands at 3306, 3234 and 3156 cm -1 . Heating the hydrazine derivative 5 under reflux with the appropriate aldehydes e.g. 1,3-diphenylpyrazole-5-carbaldehyde, thiophene-3-carbaldehyde or pyridine-4-carbaldehyde in absolute ethanol afforded 4-substituted (methylidenehydrazino)-5,6,7,8-tetrahydro [1] benzothieno [2,3-d] pyrimidine derivatives 6a-c in good yields (Scheme 2). IR spectra of compounds 6a-c showed absorption bands for NH group at 3288-3108 cm -1 , beside the absorption bands due to C=N, C=C and C−S−C functions. 1 H NMR spectra of 6a, 6b and 6c showed a singlet at 9.08, 8.51 and 7.55 ppm, respectively due to N=CH. The spectra of 6a, 6b and 6c also showed a deuteriumexchangeable signal for the NH proton at 11.68, 10.48 and 8.10 ppm, respectively in addition to the other signals at their expected chemical shifts. 13 C NMR spectrum of 6b showed three signals for five methine carbons at 124.54, 135.42 and 148.84 ppm due to pyridine C 3,5 , N=CH and pyridine C 2,6 , respectively and one signal at 145.03 ppm corresponding to the pyridine C 4 quaternary carbon. In addition, the spectrum showed the signals due to tetrahydrobenzothienopyrimidine carbons at their expected chemical shifts.
The peaks due to quaternary carbon atoms of the structure disappeared on DEPT experimentation. Condensation of 5 with 1,3-dicarbonyl compounds such as benzoylacetone and ethyl benzoylpyruvate in accordance with the reported procedures [8, 12] 
The IR spectra of compounds 7a,b lacked the stretching NH bands present in the precursor. The 1 H NMR spectra of 7a and 7b showed a singlet at 6.40 and 7.35 ppm, respectively due to pyrazolyl-C 4 -H in addition to the other signals due to aromatic protons and tetrahydrobenzothienopyrimidine nucleus at their expected chemical shifts.
The
13 C NMR spectrum of 7b showed two high field signals for the methyl and methylene carbons of the O-ethyl group at 14.35 and 44.17 ppm, respectively. It also showed six signals due to the methine carbons of the pyrazolyl C 4 and phenyl C 4 , C 2 , C 5 , C 3 and C 6 at 98. 35 [4,3-c] pyrimidine derivatives 8a,b, in the present study, was achieved via one pot reaction of the 4-hydrazino derivative 5 with the appropriate carboxylic acid in presence of phosphorous oxychloride. The IR spectra of compounds 8a,b lacked the absorption bands due to NH functions present in the precursor. The 1 H NMR spectra of compound 8a,b showed signals due to aromatic protons in addition to the other signals for the tetrahydrobenzothienotriazolopyrimidine-C 5 , [8] [9] [10] [11] -protons at their expected chemical shifts. 13 C NMR spectrum of 8a showed four signals for the highly shielded methylene carbons C 10 , C 9 , C 11 and C 8 [4,3-c] pyrimidin-3-ylsulfanyl)acetamides derivatives 10a-c. The IR spectra of compounds 10a-c showed absorption bands due to NH function at 3383-3114 and C=O moiety at 1676-1685 cm -1 . The 1 H NMR spectra of compounds 10a, 10b and 10c showed a singlet at 4.04, 4.03 and 4.13 ppm, respectively for SCH 2 protons. The spectra of 10a, 10b and 10c also showed a deuterium-exchangeable singlet at 10.19, 10.11 and 10.18 ppm, respectively for NH protons. In addition to the other signals at their expected chemical shifts. 13 C NMR spectrum of 10b showed in addition to the signals due to the tetrahydrobenzothienotriazolopyrimidine carbons at their expected chemical shifts, two shielded signals due to CH 3 and SCH 2 at 20.98 and 39.20 ppm, respectively and two signals at 119.66 and 129.67 ppm due to four methine carbons of the 4-tolyl moiety indicating the equivalency between the two ortho and two meta carbons. The spectrum also showed two signals corresponding to the quaternary C 4 and C 1 of the phenyl group at 133.12 and 136.55 ppm respectively while the most deshielded signal at 166.10 ppm was characterized for C=O. The peaks due to quaternary carbon atoms of the structure disappeared on DEPT experimentation.
Antimicrobial activity
Tab. 1.
The inhibition zones (IZ) in mm diameter.
Compound No. S. aureus E. coli P. aeruginosa C. albicans 4a  -15  16  22  4b  18  15.5  17  20  4c  -16  19  16  4d  -16  16  16  6a  -13  -18  6b  21  16  -20  6c  21  17  20  20  7a  -15  16  15  7b  -15  16  18  8b  -16  -20  10a  -16  -17  10b  -17  -22  10c  -17  -20  Ampicillin  25  28  32  -Clotrimazole  ---35 (-) no inhibition zone
Most of the prepared compounds were in vitro evaluated for their antimicrobial activity using the cup diffusion technique [35] The data indicate that, compounds 4a and 10b were the most active among the tested compounds against C. albicans showing IZ = 22 mm and MIC = MBC = 31.25 μg/ml, or about one-sixth the activity of Clotrimazole with no significant antibacterial activity. In addition, compounds 4b, 6b, 6c, 8b and 10c showed MIC = MBC = 31.25 μg/ml against C. albicans but their IZ = 20 mm. Replacement of the morpholino moiety at 4-position of the tetrahydrobenzothienopyrimidine nucleus in 4a by a piperidine moiety gave compound 4b that showed nearly the same activity of 4a against C. albicans (IZ = 20 mm, MIC = MBC = 31.25 μg/ ml). In addition, compound 4b showed activity against S. aureus (IZ = 18 mm, MIC = MBC = 62.5 μg/ml). On the other hand, replacement of the morpholino moiety in 4a by 4-benzylpiperazine in 4c led to increase the antibacterial potency of 4c against P. aeruginosa showing IZ = 19 mm, MIC = MBC = 62.5 μg/ml and reduced the antifungal activity.
Tab. 2.
MIC and MBC in μg/ml of the most active compounds. Introduction of a methylidenehydrazino linkage at the 4-position of the tetrahydrobenzothienopyrimidine nucleus as in 6b enhanced the antibacterial activity against S. aureus (IZ = 21 mm, MIC = 62.5 μg/ml and MBC = 125 μg/ml) and retained the same antifungal potency as compound 4b (IZ = 20 mm, MIC = MBC = 31.25 μg/ml). Replacement of the pyridinyl function present in 6b by a thiophene moiety led to compound 6c which was equipotent with 6b against C. albicans (IZ = 20 mm, MIC = MBC = 31.25 μg/ml), while the potency of 6c against S. aureus as compaired with 6b was diminished (IZ = 21 mm, MIC = MBC = 125 μg/ml). However, 4c and 6c showed the highest antibacterial potency against P. aeruginosa among the tested compounds with IZ = 19 and 20 mm, respectively and MIC = MBC = 62.5 μg/ml or nearly one-third the activity of Ampicillin.
Experimental
Chemistry
Melting points were determined in open-glass capillaries on a Gallen-Kamp melting point apparatus and are uncorrected. The IR spectra (KBr) were recorded on a Perkin-Elmer 1430 spectrophotometer. The 1 H NMR spectra were determined on a JNM-LA 400 FT NMR system (400 MHz), Faculty of Science, Assuit University and on Jeol (500 MHz), Faculty of Science, Alexandria Univesity, using TMS as internal standard. The chemical shifts are given in ppm δ values (s, singlet; d, doublet; t, triplet and m, multiplet). 13 C NMR spectra were determined on Jeol (125 MHz), Faculty of Science, Alexandria Univesity, using TMS as internal standard. Mass spectra were run on a Finnigan mass spectrometer model S SQ/7000 (70 ev), Faculty of Science, Cairo University. Microanalysis were performed at the Microanalytical Unit, Faculty of Science, Cairo University and The Microanalytical Unit, Faculty of Science, Assuit University, A. R. Egypt. The results of the microanalysis were within ±0.4% of the calculated values. Follow up the reactions and checking the homogeneity of the compounds were made by ascending TLC run on silica gel G (Merck 60) coated glass plates. The spots were visualized, by exposure to iodine vapour or UV-Lamp at λ 254 nm for few seconds.
Compounds 2 [29, 30] , 3 [31] , and 9 [34] were prepared according to the published procedures. Compound 8a has been previously synthesized in a two step procedure [32, 33] through condensation of the 4-hydrazino derivative 5 [32] with 3-chlorobenzaldehyde and further ring closure of the produced Schiff 's base using bromine in acetic acid at 45°C.
General procedure for the preparation of 4-(substituted amino)-5,6,7,8-tetrahydro-[1]benzothieno[2,3-d]pyrimidines (4a-d)
A mixture of 3 (0.67 gm, 3 mmol) and the appropriate amine (a-d) (6 mmol) in 5 ml DMF was stirred at (60-80°C) for 6 h, cooled, added to ice cold water and the obtained product was filtered, washed with water and crystallized from the appropriate solvent to afford 4a-d in 59-70% yields.
4-(Morpholin-4-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine (4a)
Pale brown crystals (59%, EtOH); mp: 98-99°C; IR (KBr) ν (cm 
4-(Piperidin-1-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine (4b)
Off-white powder (68%, CHCl 3 -1-yl) -5,6,7,8-tetrahydro[1] benzothieno [2,3-d] 
4-(4-Benzylpiperazin
4-(4-Benzylpiperidin-1-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine (4d)
Brown crystals (65%, EtOH); mp: 142-143°C; IR (KBr) ν (cm [31] according to the previously described method [32] . Yield (79%); mp: 175°C (reported 180-181°C) [32] . IR (cm -1 ): 3306, 3234, 3156 (NH), 1627 (C=N), 1566 (δ NH), 1502 (C=C), 1297, 1069 (C-S-C).
General procedure for the preparation of 4-substituted (methylidenehydrazino)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidines (6a-c)
To a solution of 5 (0.44 g, 2 mmol) in 10 ml absolute ethanol the appropriate aldehyde (2 mmol) was added and the mixture was refluxed for 2 h. The solid obtained, was filtered off and crystallized from the appropriate solvent to afford 6a-c in 68-75% yields.
4-{2-[(1,3-Diphenyl-1H-pyrazol-5-yl)methylidene]hydrazino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine (6a)
Yellow crystals (75%, EtOH); mp: 220°C; IR (KBr) ν (cm A mixture of 5 (0.44 g, 2 mmol) and the appropriate 1,3-dicarbonyl compounds (2 mmol) was refluxed in 10 ml ethanol for 2 h and then cooled. The obtained product was filtered, dried and crystallized from the appropriate solvent to give 7a,b in 65-66% yields. -5,6,7,8-tetrahydro [1] benzothieno [2,3- Ethyl 5-phenyl-1- (5,6,7,8-tetrahydro[1] benzothieno [2,3- A mixture of 5 (0.44 g, 2 mmol) and the appropriate carboxylic acid (2 mmol) in 5 ml phosphorous oxychloride was refluxed for 5 h and left to cool. The product was poured into crushed ice while stirring, filtered washed with sodium bicarbonate solution then with water, left to dry and crystallized from the appropriate solvent to afford 8a,b in 70-85% yields. -8,9,10,11-tetrahydro [1] benzothieno [3,2-e] [1, 2, 4] triazolo [4,3- To a mixture of 9 (0.52 g, 2 mmol) and anhydrous K 2 CO 3 (0.28 g, 2 mmol) in 20 ml dry acetone, the appropriate 4-substituted chloroacetanilide (2 mmol) was added and the resulting mixture was stirred at room temperature for 3 h. The reaction mixture was poured into crushed ice and the product was filtered, washed with water, dried and crystallized from the appropriate solvent to give 10a-c in 68-74% yields.
4-(3-Methyl-5-phenyl-1H-pyrazol-1-yl)
3-(3-Chlorophenyl)
N-Phenyl-2-(8,9,10,11-tetrahydro [1] benzothieno [3,2- 
In vitro antimicrobial screening
Inhibition zone measurement
Using the cup diffusion technique [35] , the products as 1 mg/ml solution in DMF were in vitro evaluated for antibacterial activity against Staphylococcus aureus (ATCC 6538), Escherichia coli (ATCC 8735) and Pseudomonas aeruginosa (ATCC 9027) and for antifungal activity against Candida albicans (ATCC 10231).
The activities were estimated as zones of inhibition in mm diameter (Table 1) . A 5 μg/ml solution of Ampicillin and a solution containing 0.01% of Clotrimazole in DMF were used as reference standards. Each cup (8 mm in diameter) received 0.1 ml of the test compound or reference standard solution. DMF did not show any inhibition zones.
Minimal inhibitory concentration (MIC) measurement
The bacteriostatic activity of the active compounds (having inhibition zones (IZ) ≥ 18 mm) was then evaluated using the two fold serial dilution technique [36] . Two fold serial dilutions of the test compounds and reference drugs solutions were prepared using the proper nutrient broth. The final concentration of the solutions varied between 500 and 7.81 μg/ml with the concentration of DMF not exceeding 2.5%. The tubes were then inoculated with the test organisms, grown in their suitable broth at 37 °C for 24 hours for bacteria and 48 hours for fungi (about 1×10 6 cells/ml), each 5 ml received 0.1 ml of the above inoculum and were incubated at 37 °C for 48 hours. The lowest concentration showing no growth was taken as the minimum inhibitory concentration (MIC) ( Table 2) .
Minimal bacteriostatic concentration (MBC) measurement
To determine the minimum bactericidal concentration (MBC), a loopful from the tube not showing visible growth in the MIC experiment was spread over a quarter of Muller-Hinton agar plate. After incubation for 18 hours, the plates were examined for growth. The tube containing the lowest concentration of the test compound that prevented growth on subculture plates were judged to contain the MBC of that compound for the respective test organism (Table 2) .
Conclusions
The overall results indicated that, most of the tested compounds (4a, 4b, 6b, 6c, 8b, 10b and 10c) showed antifungal activity against C. albicans, few compounds exhibited antibacterial activity against S. aureus (4b, 6b and 6c) and P. aeruginosa (4c and 6c) while none of the tested compounds showed significant antibacterial activity against E. coli.
